SANUWAVE Health, Inc. (SNWV)
USD 30.41
(2.03%)
USD 30.41
(2.03%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 14.36 Million USD | 9.67% |
| 2022 | 12.41 Million USD | 54.67% |
| 2021 | 8.02 Million USD | 177.12% |
| 2020 | 2.89 Million USD | 491.14% |
| 2019 | 489.8 Thousand USD | -57.64% |
| 2018 | 1.15 Million USD | 132.88% |
| 2017 | 496.55 Thousand USD | -38.77% |
| 2016 | 810.93 Thousand USD | 19.16% |
| 2015 | 680.53 Thousand USD | 8.47% |
| 2014 | 627.39 Thousand USD | 2.81% |
| 2013 | 610.23 Thousand USD | 11.16% |
| 2012 | 548.96 Thousand USD | 1.53% |
| 2011 | 540.68 Thousand USD | 13.08% |
| 2010 | 478.12 Thousand USD | 9.93% |
| 2009 | 434.93 Thousand USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 4.2 Million USD | -9.56% |
| 2024 Q2 | 5.06 Million USD | 24.7% |
| 2023 Q2 | 3.47 Million USD | 38.2% |
| 2023 FY | 13.61 Million USD | 9.67% |
| 2023 Q3 | 3.54 Million USD | 1.96% |
| 2023 Q4 | 4.64 Million USD | 31.21% |
| 2023 Q1 | 2.51 Million USD | -33.15% |
| 2022 FY | 12.41 Million USD | 54.67% |
| 2022 Q2 | 2.78 Million USD | 20.82% |
| 2022 Q1 | 2.3 Million USD | -21.35% |
| 2022 Q3 | 3.56 Million USD | 27.78% |
| 2022 Q4 | 3.75 Million USD | 5.59% |
| 2021 Q1 | 1.06 Million USD | -22.0% |
| 2021 FY | 8.02 Million USD | 177.12% |
| 2021 Q2 | 1.86 Million USD | 75.4% |
| 2021 Q3 | 2.17 Million USD | 16.6% |
| 2021 Q4 | 2.93 Million USD | 35.12% |
| 2020 Q3 | 1.41 Million USD | 2390.59% |
| 2020 FY | 2.89 Million USD | 491.14% |
| 2020 Q1 | 59.71 Thousand USD | -70.13% |
| 2020 Q2 | 56.95 Thousand USD | -4.62% |
| 2020 Q4 | 1.36 Million USD | -4.1% |
| 2019 Q4 | 199.88 Thousand USD | 167.52% |
| 2019 FY | 489.8 Thousand USD | -57.64% |
| 2019 Q1 | 84.11 Thousand USD | -69.83% |
| 2019 Q2 | 131.09 Thousand USD | 55.86% |
| 2019 Q3 | 74.71 Thousand USD | -43.01% |
| 2018 Q1 | 178.8 Thousand USD | -17.17% |
| 2018 FY | 1.15 Million USD | 132.88% |
| 2018 Q4 | 278.82 Thousand USD | -32.36% |
| 2018 Q3 | 412.19 Thousand USD | 43.84% |
| 2018 Q2 | 286.56 Thousand USD | 60.27% |
| 2017 Q2 | 86.35 Thousand USD | -8.55% |
| 2017 FY | 496.55 Thousand USD | -38.77% |
| 2017 Q1 | 94.42 Thousand USD | -71.59% |
| 2017 Q4 | 215.88 Thousand USD | 116.09% |
| 2017 Q3 | 99.9 Thousand USD | 15.69% |
| 2016 Q4 | 332.39 Thousand USD | 111.75% |
| 2016 Q1 | 196.14 Thousand USD | -24.52% |
| 2016 Q3 | 156.97 Thousand USD | 25.16% |
| 2016 FY | 810.93 Thousand USD | 19.16% |
| 2016 Q2 | 125.41 Thousand USD | -36.06% |
| 2015 Q4 | 259.84 Thousand USD | 147.82% |
| 2015 Q1 | 151.63 Thousand USD | -8.93% |
| 2015 FY | 680.53 Thousand USD | 8.47% |
| 2015 Q3 | 104.85 Thousand USD | -36.14% |
| 2015 Q2 | 164.2 Thousand USD | 8.29% |
| 2014 Q1 | 126.76 Thousand USD | -39.36% |
| 2014 Q4 | 166.5 Thousand USD | 4.44% |
| 2014 Q3 | 159.41 Thousand USD | -8.76% |
| 2014 Q2 | 174.71 Thousand USD | 37.83% |
| 2014 FY | 627.39 Thousand USD | 2.81% |
| 2013 Q2 | 136.83 Thousand USD | -5.91% |
| 2013 Q3 | 118.95 Thousand USD | -13.07% |
| 2013 Q4 | 209.02 Thousand USD | 75.72% |
| 2013 FY | 610.23 Thousand USD | 11.16% |
| 2013 Q1 | 145.42 Thousand USD | 21.48% |
| 2012 Q1 | 166.76 Thousand USD | 9.35% |
| 2012 Q2 | 128.19 Thousand USD | -23.13% |
| 2012 Q3 | 134.29 Thousand USD | 4.75% |
| 2012 Q4 | 119.7 Thousand USD | -10.86% |
| 2012 FY | 548.96 Thousand USD | 1.53% |
| 2011 Q3 | 113.2 Thousand USD | -2.84% |
| 2011 Q4 | 152.5 Thousand USD | 34.72% |
| 2011 Q2 | 116.51 Thousand USD | -26.47% |
| 2011 FY | 540.68 Thousand USD | 13.08% |
| 2011 Q1 | 158.45 Thousand USD | 14.85% |
| 2010 Q3 | 168.41 Thousand USD | 120.75% |
| 2010 Q4 | 137.96 Thousand USD | -18.08% |
| 2010 FY | 478.12 Thousand USD | 9.93% |
| 2010 Q1 | 95.45 Thousand USD | 273.86% |
| 2010 Q2 | 76.29 Thousand USD | -20.08% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q4 | 25.53 Thousand USD | -75.45% |
| 2009 FY | 434.93 Thousand USD | 0.0% |
| 2009 Q3 | 104.01 Thousand USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 466.38 Thousand USD | -2979.625% |
| IR-Med Inc. | -17 Thousand USD | 84588.235% |
| Polarean Imaging plc | 335.48 Thousand USD | -4181.29% |
| Medical Supply International USA, Inc. | 1.75 Million USD | -716.693% |
| Avitar, Inc. | 836.7 Thousand USD | -1616.621% |
| AVITA Medical, Inc. | 41.68 Million USD | 65.546% |
| Manhattan Scientifics, Inc. | -1000.00 USD | 1436400.0% |
| Össur hf. | 485.57 Million USD | 97.042% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 7453.536% |
| QHSLab, Inc. | 793.6 Thousand USD | -1709.838% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 485.57 Million USD | 97.042% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | 14.221% |
| Escalon Medical Corp. | 5.14 Million USD | -179.1% |
| Aurora Spine Corporation | 8.21 Million USD | -74.918% |
| BrainsWay Ltd. | 23.09 Million USD | 37.798% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 105.1 Thousand USD | -13565.642% |
| Hamilton Thorne Ltd. | 35.08 Million USD | 59.06% |
| Vivos Inc. | -6036.00 USD | 238055.6% |
| MicroPort Scientific Corporation | 532.09 Million USD | 97.301% |
| Kelyniam Global, Inc. | 2.03 Million USD | -605.425% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 1998.012% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | -25279.015% |
| Nanomix Corporation | -69.45 Thousand USD | 20778.684% |
| Theraclion SA | -1.08 Million USD | 1429.433% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | -2344.558% |
| Positron Corporation | -353.46 Thousand USD | 4163.486% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.04 Million USD | -1273.786% |
| Lombard Medical, Inc. | 955 Thousand USD | -1403.979% |
| ALR Technologies Inc. | 4945.00 USD | -290355.005% |
| Stratec SE | 71.58 Million USD | 79.937% |
| Vycor Medical, Inc. | 1.31 Million USD | -991.7% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | 111441.085% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -6858.177% |
| VMS Rehab Systems, Inc. | -10.44 USD | 137576728.352% |
| Guided Therapeutics, Inc. | 36 Thousand USD | -39797.222% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | -5247.795% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | -8000.00 USD | 179637.5% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | -1212.832% |
| Urologix, Inc. | 6.09 Million USD | -135.73% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 4635.336% |
| SS Innovations International, Inc. | 713.44 Thousand USD | -1913.184% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 3.91 Billion USD | 99.633% |
| NIOX Group Plc | 28.13 Million USD | 48.947% |
| Fuse Medical, Inc. | 10.73 Million USD | -33.81% |
| Broncus Holding Corporation | 7.22 Million USD | -98.741% |
| Brain Scientific Inc. | 54.32 Thousand USD | -26339.024% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | -1696.359% |
| Health Logic Interactive Inc. | - USD | -Infinity% |